NCT07600476 A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07376317 Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT07251335 Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active Search and Prevention of Occupational Diseases Based on Recent INAIL Criteria Status RECRUITING Phase N/A
NCT07148245 Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma Status RECRUITING Phase N/A
NCT07068074 A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients Status NOT_YET_RECRUITING Phase PHASE3
NCT06999980 Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation) Status RECRUITING Phase PHASE2
NCT06984328 Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06967961 Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers Status RECRUITING Phase NA
NCT06624644 A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma Status RECRUITING Phase PHASE2/PHASE3
NCT06319196 Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma Status RECRUITING Phase PHASE2
NCT06223659 EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers Status RECRUITING Phase PHASE2
NCT06194929 Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma Status RECRUITING Phase PHASE1/PHASE2
NCT06090266 A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents Status RECRUITING Phase PHASE1/PHASE2
NCT06008977 Exercise to Boost Response to Checkpoint Blockade Immunotherapy Status ACTIVE_NOT_RECRUITING Phase NA
NCT05970497 A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05824975 A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) Status RECRUITING Phase PHASE1/PHASE2
NCT05675709 Enhancing Skin Cancer Early Detection and Treatment in Primary Care Status COMPLETED Phase NA